The Hirshberg Foundation for Pancreatic Cancer Research is proud to announce the launch of the PNET Pathway Grant Program, a new research initiative focused on accelerating discoveries in pancreatic neuroendocrine tumors (PNETs).
This targeted program will support high-impact scientific projects aimed at improving our understanding of PNET biology, predicting disease progression, and advancing innovative treatment strategies for patients.
Pancreatic neuroendocrine tumors are a distinct type of pancreatic tumor that behave very differently from the more common pancreatic adenocarcinoma (PDAC). While some PNETs remain stable for years and may only require monitoring, others progress and require more aggressive treatment. Because the biology of these tumors can vary significantly from patient to patient, physicians are often faced with difficult decisions about when treatment is necessary and when careful surveillance may be the best approach.
The PNET Pathway Grant Program was designed to help answer these critical questions by supporting research that can lead to earlier detection, more precise prognostic tools, and new therapeutic options.
The name “Pathway” reflects the biological signaling pathways that drive these tumors as well as the goal of creating a clear pathway from scientific discovery to improved patient care.
Applications Now Open
Applications for the inaugural PNET Pathway Grant Program cycle are now open, with a submission deadline of May 15, 2026. Eligible researchers are invited to submit proposals that address the program’s priority research areas.
As we continue to support the next generation of discoveries, we can expand the impact of pancreas cancer research. Thanks to the generosity of supporters, the Hirshberg Foundation continues to develop the scope of the research it can support, investing in promising ideas and the scientists who are pushing the field forward.
The launch of the PNET Pathway Grant Program represents an important step toward improving outcomes for all patients facing pancreatic tumors.
By supporting innovative research today, the Foundation is helping create new pathways toward better treatments and a brighter future for patients and families affected by pancreatic cancer.
Donate today towards the PNET Pathway Grant Program
